265 related articles for article (PubMed ID: 36567145)
41. Establishment and verification of a prediction model based on clinical characteristics and computed tomography radiomics parameters for distinguishing benign and malignant pulmonary nodules.
Hou X; Wu M; Chen J; Zhang R; Wang Y; Zhang S; Yuan Z; Feng J; Xu L
J Thorac Dis; 2024 Mar; 16(3):1984-1995. PubMed ID: 38617763
[TBL] [Abstract][Full Text] [Related]
42. Integrative nomogram of intratumoral, peritumoral, and lymph node radiomic features for prediction of lymph node metastasis in cT1N0M0 lung adenocarcinomas.
Das SK; Fang KW; Xu L; Li B; Zhang X; Yang HF
Sci Rep; 2021 May; 11(1):10829. PubMed ID: 34031529
[TBL] [Abstract][Full Text] [Related]
43. 2D and 3D texture analysis to predict lymphovascular invasion in lung adenocarcinoma.
Yang G; Nie P; Zhao L; Guo J; Xue W; Yan L; Cui J; Wang Z
Eur J Radiol; 2020 Aug; 129():109111. PubMed ID: 32559593
[TBL] [Abstract][Full Text] [Related]
44. A Combined Nomogram Model to Preoperatively Predict Histologic Grade in Pancreatic Neuroendocrine Tumors.
Liang W; Yang P; Huang R; Xu L; Wang J; Liu W; Zhang L; Wan D; Huang Q; Lu Y; Kuang Y; Niu T
Clin Cancer Res; 2019 Jan; 25(2):584-594. PubMed ID: 30397175
[TBL] [Abstract][Full Text] [Related]
45. Preoperative contrast-enhanced computed tomography-based radiomics model for overall survival prediction in hepatocellular carcinoma.
Deng PZ; Zhao BG; Huang XH; Xu TF; Chen ZJ; Wei QF; Liu XY; Guo YQ; Yuan SG; Liao WJ
World J Gastroenterol; 2022 Aug; 28(31):4376-4389. PubMed ID: 36159012
[TBL] [Abstract][Full Text] [Related]
46. MRI-Based Radiomics Nomogram as a Potential Biomarker to Predict the EGFR Mutations in Exon 19 and 21 Based on Thoracic Spinal Metastases in Lung Adenocarcinoma.
Cao R; Dong Y; Wang X; Ren M; Wang X; Zhao N; Yu T; Zhang L; Luo Y; Cui EN; Jiang X
Acad Radiol; 2022 Mar; 29(3):e9-e17. PubMed ID: 34332860
[TBL] [Abstract][Full Text] [Related]
47. Computed Tomography-Based Radiomics Model to Predict Central Cervical Lymph Node Metastases in Papillary Thyroid Carcinoma: A Multicenter Study.
Li J; Wu X; Mao N; Zheng G; Zhang H; Mou Y; Jia C; Mi J; Song X
Front Endocrinol (Lausanne); 2021; 12():741698. PubMed ID: 34745008
[TBL] [Abstract][Full Text] [Related]
48. A Comprehensive Nomogram Combining CT Imaging with Clinical Features for Prediction of Lymph Node Metastasis in Stage I-IIIB Non-small Cell Lung Cancer.
Zheng X; Shao J; Zhou L; Wang L; Ge Y; Wang G; Feng F
Ther Innov Regul Sci; 2022 Jan; 56(1):155-167. PubMed ID: 34699046
[TBL] [Abstract][Full Text] [Related]
49. A PET/CT nomogram incorporating SUVmax and CT radiomics for preoperative nodal staging in non-small cell lung cancer.
Xie Y; Zhao H; Guo Y; Meng F; Liu X; Zhang Y; Huai X; Wong Q; Fu Y; Zhang H
Eur Radiol; 2021 Aug; 31(8):6030-6038. PubMed ID: 33560457
[TBL] [Abstract][Full Text] [Related]
50. Computed Tomography-based Radiomics Nomogram for the Preoperative Prediction of Tumor Deposits and Clinical Outcomes in Colon Cancer: a Multicenter Study.
Li M; Xu G; Chen Q; Xue T; Peng H; Wang Y; Shi H; Duan S; Feng F
Acad Radiol; 2023 Aug; 30(8):1572-1583. PubMed ID: 36566155
[TBL] [Abstract][Full Text] [Related]
51. Multi-classification model incorporating radiomics and clinic-radiological features for predicting invasiveness and differentiation of pulmonary adenocarcinoma nodules.
Sun H; Zhang C; Ouyang A; Dai Z; Song P; Yao J
Biomed Eng Online; 2023 Nov; 22(1):112. PubMed ID: 38037082
[TBL] [Abstract][Full Text] [Related]
52. An individualised radiomics composite model predicting prognosis of stage 1 solid lung adenocarcinoma.
Chen H; Liang M; Li X; Wu T; Zhang L; Liu X
Clin Radiol; 2020 Jul; 75(7):562.e11-562.e19. PubMed ID: 32307110
[TBL] [Abstract][Full Text] [Related]
53. Development and Validation of a Radiomics Nomogram for Differentiating Pulmonary Cryptococcosis and Lung Adenocarcinoma in Solitary Pulmonary Solid Nodule.
Zhao J; Sun L; Sun K; Wang T; Wang B; Yang Y; Wu C; Sun X
Front Oncol; 2021; 11():759840. PubMed ID: 34858836
[TBL] [Abstract][Full Text] [Related]
54. A Combination of Radiomic Features, Imaging Characteristics, and Serum Tumor Biomarkers to Predict the Possibility of the High-Grade Subtypes of Lung Adenocarcinoma.
Liu Y; Chang Y; Zha X; Bao J; Wu Q; Dai H; Hu C
Acad Radiol; 2022 Dec; 29(12):1792-1801. PubMed ID: 35351366
[TBL] [Abstract][Full Text] [Related]
55. The predictive value of CT-based radiomics in differentiating indolent from invasive lung adenocarcinoma in patients with pulmonary nodules.
She Y; Zhang L; Zhu H; Dai C; Xie D; Xie H; Zhang W; Zhao L; Zou L; Fei K; Sun X; Chen C
Eur Radiol; 2018 Dec; 28(12):5121-5128. PubMed ID: 29869172
[TBL] [Abstract][Full Text] [Related]
56. [Radiomics nomogram of MR: a prediction of cervical lymph node metastasis in laryngeal cancer].
Jia CL; Cao Y; Song Q; Zhang WB; Li JJ; Wu XX; Yu PY; Mou YK; Mao N; Song XC
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2020 Dec; 55(12):1154-1161. PubMed ID: 33342131
[No Abstract] [Full Text] [Related]
57. A Nomogram Combined Radiomics and Clinical Features as Imaging Biomarkers for Prediction of Visceral Pleural Invasion in Lung Adenocarcinoma.
Zha X; Liu Y; Ping X; Bao J; Wu Q; Hu S; Hu C
Front Oncol; 2022; 12():876264. PubMed ID: 35692792
[TBL] [Abstract][Full Text] [Related]
58. Preoperative prediction of the degree of differentiation of lung adenocarcinoma presenting as sub-solid or solid nodules with a radiomics nomogram.
Yang Y; Tan M; Ma W; Duan S; Huang X; Jin L; Tang L; Li M
Clin Radiol; 2022 Sep; 77(9):e680-e688. PubMed ID: 35718542
[TBL] [Abstract][Full Text] [Related]
59. Development and Validation a Nomogram Incorporating CT Radiomics Signatures and Radiological Features for Differentiating Invasive Adenocarcinoma From Adenocarcinoma
Shi L; Shi W; Peng X; Zhan Y; Zhou L; Wang Y; Feng M; Zhao J; Shan F; Liu L
Front Oncol; 2021; 11():618677. PubMed ID: 33968722
[TBL] [Abstract][Full Text] [Related]
60. Extrathyroidal Extension Prediction of Papillary Thyroid Cancer With Computed Tomography Based Radiomics Nomogram: A Multicenter Study.
Yu P; Wu X; Li J; Mao N; Zhang H; Zheng G; Han X; Dong L; Che K; Wang Q; Li G; Mou Y; Song X
Front Endocrinol (Lausanne); 2022; 13():874396. PubMed ID: 35721715
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
